A nanoparticle size series for in vivo fluorescence imaging
- PMID: 20886481
- PMCID: PMC3035057
- DOI: 10.1002/anie.201003142
A nanoparticle size series for in vivo fluorescence imaging
Figures



Similar articles
-
Mitigation of quantum dot cytotoxicity by microencapsulation.PLoS One. 2011;6(7):e22079. doi: 10.1371/journal.pone.0022079. Epub 2011 Jul 21. PLoS One. 2011. PMID: 21814567 Free PMC article.
-
Lighting-up the dynamics of telomerization and DNA replication by CdSe-ZnS quantum dots.J Am Chem Soc. 2003 Nov 19;125(46):13918-9. doi: 10.1021/ja035848c. J Am Chem Soc. 2003. PMID: 14611202
-
Photoactivation of CdSe/ZnS quantum dots embedded in silica colloids.Small. 2008 Sep;4(9):1516-26. doi: 10.1002/smll.200700997. Small. 2008. PMID: 18712754
-
Semiconductor quantum dots as biological imaging agents.Angew Chem Int Ed Engl. 2004 Aug 13;43(32):4129-31. doi: 10.1002/anie.200301758. Angew Chem Int Ed Engl. 2004. PMID: 15307073 Review. No abstract available.
-
Stability and fluorescence quantum yield of CdSe-ZnS quantum dots--influence of the thickness of the ZnS shell.Ann N Y Acad Sci. 2008;1130:235-41. doi: 10.1196/annals.1430.021. Ann N Y Acad Sci. 2008. PMID: 18596353 Review.
Cited by
-
Inorganic nanosystems for therapeutic delivery: status and prospects.Adv Drug Deliv Rev. 2013 Jan;65(1):93-9. doi: 10.1016/j.addr.2012.08.011. Epub 2012 Sep 4. Adv Drug Deliv Rev. 2013. PMID: 22981754 Free PMC article. Review.
-
Evaluating the pharmacokinetics and in vivo cancer targeting capability of Au nanocages by positron emission tomography imaging.ACS Nano. 2012 Jul 24;6(7):5880-8. doi: 10.1021/nn300464r. Epub 2012 Jun 19. ACS Nano. 2012. PMID: 22690722 Free PMC article.
-
Nanotechnology in cancer diagnosis: progress, challenges and opportunities.J Hematol Oncol. 2019 Dec 17;12(1):137. doi: 10.1186/s13045-019-0833-3. J Hematol Oncol. 2019. PMID: 31847897 Free PMC article. Review.
-
Targeted Cytokine Delivery for Cancer Treatment: Engineering and Biological Effects.Pharmaceutics. 2023 Jan 19;15(2):336. doi: 10.3390/pharmaceutics15020336. Pharmaceutics. 2023. PMID: 36839658 Free PMC article. Review.
-
Enhancing cancer immunotherapy with nanomedicine.Nat Rev Immunol. 2020 May;20(5):321-334. doi: 10.1038/s41577-019-0269-6. Epub 2020 Jan 31. Nat Rev Immunol. 2020. PMID: 32005979 Free PMC article. Review.
References
-
- Jain RK. Advanced Drug Delivery Reviews. 2001;46:149. - PubMed
-
- Nel AE, Madler L, Velegol D, Xia T, Hoek EM, Somasundaran P, Klaessig F, Castranova V, Thompson M. Nat Mater. 2009;8:543. - PubMed
-
- Perrault SD, Walkey C, Jennings T, Fischer HC, Chan WCW. Nano Letters. 2009;9:1909. - PubMed
-
- Yuan F, Dellian M, Fukumura D, Leunig M, Berk DA, Torchilin VP, Jain RK. Cancer Research. 1995;55:3752. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
- T32 CA073479/CA/NCI NIH HHS/United States
- 1U54-CA119349/CA/NCI NIH HHS/United States
- R01 CA126642/CA/NCI NIH HHS/United States
- R01-CA085140/CA/NCI NIH HHS/United States
- R01 CA085140/CA/NCI NIH HHS/United States
- R01-CA115767/CA/NCI NIH HHS/United States
- P01-CA080124/CA/NCI NIH HHS/United States
- R01-CA096915/CA/NCI NIH HHS/United States
- U54 CA119349/CA/NCI NIH HHS/United States
- R01 CA115767/CA/NCI NIH HHS/United States
- R01 CA096915/CA/NCI NIH HHS/United States
- P01 CA080124/CA/NCI NIH HHS/United States
- R01-CA126642/CA/NCI NIH HHS/United States
LinkOut - more resources
Full Text Sources
Other Literature Sources